RhumbLine Advisers
LOGC

RhumbLine Advisers’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,340
Closed -$97K 3158
2021
Q1
$97K Buy
13,340
+175
+1% +$1.27K ﹤0.01% 2937
2020
Q4
$100K Buy
13,165
+1,720
+15% +$13.1K ﹤0.01% 2967
2020
Q3
$104K Sell
11,445
-2,075
-15% -$18.9K ﹤0.01% 2860
2020
Q2
$114K Buy
13,520
+3,320
+33% +$28K ﹤0.01% 2938
2020
Q1
$50K Hold
10,200
﹤0.01% 2863
2019
Q4
$73K Buy
10,200
+200
+2% +$1.43K ﹤0.01% 2899
2019
Q3
$108K Sell
10,000
-75
-0.7% -$810 ﹤0.01% 2875
2019
Q2
$131K Buy
+10,075
New +$131K ﹤0.01% 2886